June 18, 2013 |
WASHINGTON - A brand-name drug maker can be sued for violating antitrust laws if it agrees to pay a potential competitor to delay selling a generic version, the Supreme Court ruled. The 5-3 decision is expected to result in lower prescription drug prices for consumers, advocates said. The Federal Trade Commission, which has pursued suits against the drug makers, estimated that the so-called pay-for-delay deals cost consumers and health plans $3.5 billion a year. The ruling sends a warning to drug makers that try to deter generic rivals from entering the market by settling potential patent claims, paying the competitors to stay out of the market for years more.
March 25, 2013 |
WASHINGTON - A government attorney urged the Supreme Court to allow authorities to crack down on cash deals among prescription drug makers that delay the introduction of generic drugs and keep consumer prices high. The so-called pay-for-delay deals, which allow brand-name drug companies to keep cheaper generic drugs off the market for a time, violate antitrust laws, the Federal Trade Commission argued Monday. "It's unlawful to buy off the competition," said Malcolm Stewart, the deputy solicitor general who represented the FTC and the Justice Department.
January 4, 2013 |
Even the U.S. government can't rein in Google Inc.'s dominance of online search. Federal regulators ended a 19-month antitrust investigation into the Mountain View, Calif., search engine giant without imposing any major sanctions. The probe focused on complaints that Google skews its search results to favor its own products and services, which unfairly hurt competitors. It was a bitter decision for Microsoft Inc. and a cadre of other small and large rivals that feel Google remains unchecked in its dominance of the Internet search business.
November 15, 2011 |
The first sign of inclement weather in the so-called nuclear winter arrived Tuesday when Carmelo Anthony, Kevin Durant and a handful of other players sued the NBA with antitrust lawsuits at federal courts in Oakland and Minneapolis. Perennial All-Stars Anthony and Durant said the NBA violated antitrust laws and conspired to "boycott players" by attempting to force them to take massive reductions in compensation. The 30 NBA teams were named as defendants in the class-action suit filed in Oakland on behalf of the NBA's 439 players.
November 5, 2011 |
The legal war between Apple Inc. and Samsung Corp. continues to escalate, and has arrived in the halls of the European Union. The European Commission, Europe's top competition enforcer, has contacted Apple and Samsung, according to a statement posted by patent maven Florian Mueller on his FOSS Patents blog. "The commission has indeed sent requests for information to Apple and Samsung concerning the enforcement of standards-essential patents in the mobile telephony sector," the statement says.
March 19, 2011 |
Reporting from New Orleans Pro football has become a game of toxic tennis ? NFL management versus players ? with each side accusing the other of lying, hiding its true intentions, and greedily making a grab for more of the league's $9 billion in annual revenue. As the whole mess careens toward federal court, where there's a hearing scheduled for April 6 in the court of U.S. District Judge Susan Richard Nelson in Minnesota to determine whether the league is breaking antitrust laws by locking out the players, team owners will convene in New Orleans on Monday and Tuesday for their annual meetings.